Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
losartan hydrochlorothiazide · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Losartan/HCTZ |
| Name | Type | Description |
|---|---|---|
| losartan potassium (+) hydrochlorothiazide | DRUG | Patients took losartan 50 mg /HCTZ 12.5 mg orally once daily for 13 weeks. At Weeks 0, 4 and 8 if the blood pressure goal was not reached then the losartan/HCTZ combination will be titrated upwards according to the following scheme: losartan 50/HCTZ 12.5 to losartan 100/HCTZ 12.5 to losartan 100/HCTZ 25. |
Inclusion Criteria: * Patient is male or female and = 18 years of age * Patients with essential hypertension previously treated with antihypertensive medications for at least 4 weeks but did not reach the blood pressure goal Exclusion Criteria: * History of any condition, therapy, lab abnormality...